Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 238 
This article has been cited by
1Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis
Michele Barone,Endrit Shahini,Andrea Iannone,Maria Teresa Viggiani,Valeria Corvace,Mariabeatrice Principi,Alfredo Di Leo
Digestive and Liver Disease.2018;50(5)496
[DOI]
2Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis
Jawaid Shaw,Jasmohan S. Bajaj
Digestive and Liver Disease.2017;50(5)481
[DOI]
3Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications
Francesca Romana Ponziani
World Journal of Gastroenterology.2015;21(43)12322
[DOI]
4Papel de la rifaximina en el tratamiento de la encefalopatía hepática
Jordi Sanchez-Delgado,Mireia Miquel
Gastroenterología y Hepatología.2016;39(4)282
[DOI]
5The Mexican consensus on probiotics in gastroenterology
M.A. Valdovinos,E. Montijo,A.T. Abreu,S. Heller,A. González-Garay,D. Bacarreza,M. Bielsa-Fernández,M.C. Bojórquez-Ramos,F. Bosques-Padilla,A.I. Burguete-García,R. Carmona-Sánchez,A. Consuelo-Sánchez,E. Coss-Adame,J.A. Chávez-Barrera,M. de Ariño,J. Flores-Calderón,O. Gómez-Escudero,M.S. González-Huezo,M.E. Icaza-Chávez,A. Larrosa-Haro,M. Morales-Arámbula,C. Murata,J.A. Ramírez-Mayans,J.M. Remes-Troche,T. Rizo-Robles,M. Peláez-Luna,E.M. Toro-Monjaraz,A. Torre,M.E. Urquidi-Rivera,R. Vázquez,J.K. Yamamoto-Furusho,F. Guarner
Revista de Gastroenterología de México (English Edition).2017;82(2)156
[DOI]
6Efficacy and Safety of Rifaximin Versus Placebo or Other Active Drugs in Critical ill Patients With Hepatic Encephalopathy
Xianghui Han,Zhanyang Luo,Wenyi Wang,Peiyong Zheng,Tian Li,Zubing Mei,Jianyi Wang
Frontiers in Pharmacology.2021;12(2)156
[DOI]
7Manipulation of microbiota with probiotics as an alternative for treatment of hepatic encephalopathy
Renata Rivera-Flores,Segundo Morán-Villota,Luisa Cervantes-Barragán,Constantino López-Macias,Misael Uribe
Nutrition.2020;73(2)110693
[DOI]
8Probiotics for people with hepatic encephalopathy
Rohan Dalal,Richard G McGee,Stephen M Riordan,Angela C Webster
Cochrane Database of Systematic Reviews.2017;2021(1)110693
[DOI]
9Management of Neurologic Manifestations in Patients with Liver Disease
José M. Ferro,Pedro Viana,Patrícia Santos
Current Treatment Options in Neurology.2016;18(8)110693
[DOI]
10Selective improvement by rifaximin of changes in the immunophenotype in patients who improve minimal hepatic encephalopathy
Alba Mangas-Losada,Raquel García-García,Paola Leone,María Pilar Ballester,Andrea Cabrera-Pastor,Amparo Urios,Juan-José Gallego,Juan-José Martínez-Pretel,Carla Giménez-Garzó,Fernando Revert,Desamparados Escudero-García,Joan Tosca,María Pilar Ríos,Cristina Montón,Lucia Durbán,Luis Aparicio,Carmina Montoliu,Vicente Felipo
Journal of Translational Medicine.2019;17(1)110693
[DOI]
11Auditory and visual P300 event-related potentials to detect minimal hepatic encephalopathy
Ángel Daniel Santana Vargas,Fátima Higuera-De la Tijera,JOSE LUIS PEREZ HERNANDEZ
Revista Española de Enfermedades Digestivas.2021;17(1)110693
[DOI]
12Covert Hepatic Encephalopathy
Jawaid Shaw,Jasmohan S. Bajaj
Journal of Clinical Gastroenterology.2017;51(2)118
[DOI]
13Hepatic encephalopathy: Diagnosis and management
Piero Amodio
Liver International.2018;38(6)966
[DOI]
14Retracted : Efficacy of different drugs in the treatment of minimal hepatic encephalopathy: A network meta-analysis involving 826 patients based on 10 randomized controlled trials
Xiao-Jun Cai,Lei Wang,Chun-Mei Hu
Journal of Cellular Biochemistry.2018;119(10)8336
[DOI]
15Use of rifaximin in gastrointestinal and liver diseases
Rani H Shayto,Rachel Abou Mrad,Ala I Sharara
World Journal of Gastroenterology.2016;22(29)6638
[DOI]
16l-Ornithine l-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses
Roger F. Butterworth,Mark J. W. McPhail
Drugs.2019;79(S1)31
[DOI]
17Prevalence of and Factors Associated With Minimal Hepatic Encephalopathy in Patients With Cirrhosis of Liver
Abhijith Bale,C. Ganesh Pai,Shiran Shetty,Girisha Balaraju,Anurag Shetty
Journal of Clinical and Experimental Hepatology.2018;8(2)156
[DOI]
18Efficacy of l-Ornithine l-Aspartate for the Treatment of Hepatic Encephalopathy and Hyperammonemia in Cirrhosis: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Roger F. Butterworth,Gerald Kircheis,Norbert Hilger,Mark J.W. McPhail
Journal of Clinical and Experimental Hepatology.2018;8(3)301
[DOI]
19Quality of life in patients with minimal hepatic encephalopathy
Lorenzo Ridola,Silvia Nardelli,Stefania Gioia,Oliviero Riggio
World Journal of Gastroenterology.2018;24(48)5446
[DOI]
20Covert and Overt Hepatic Encephalopathy: Diagnosis and Management
Kavish R. Patidar,Jasmohan S. Bajaj
Clinical Gastroenterology and Hepatology.2015;13(12)2048
[DOI]
21Efficacy of rifaximin in the different clinical scenarios of hepatic encephalopathy
C.E. Coronel-Castillo,J. Contreras-Carmona,A.C. Frati-Munari,M. Uribe,N. Méndez-Sánchez
Revista de Gastroenterología de México (English Edition).2020;85(1)56
[DOI]
22Eficacia de la rifaximina en los diferentes escenarios clínicos de la encefalopatía hepática
C.E. Coronel-Castillo,J. Contreras-Carmona,A.C. Frati-Munari,M. Uribe,N. Méndez-Sánchez
Revista de Gastroenterología de México.2020;85(1)56
[DOI]
23Eficacia de la rifaximina en los diferentes escenarios clínicos de la encefalopatía hepática
Roger F. Butterworth
Revista de Gastroenterología de México.2020;85(1)615
[DOI]
24Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis
Qing Cao,Cheng-Bo Yu,Shi-Gui Yang,Hong-Cui Cao,Ping Chen,Min Deng,Lan-Juan Li
Hepatobiliary & Pancreatic Diseases International.2018;17(1)9
[DOI]
25Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis
Segundo Moran,Marlene López-Sánchez,María del Pilar Milke-García,Gustavo Rodríguez-Leal
World Journal of Gastroenterology.2021;27(22)3050
[DOI]
26Hyperammonemic hepatic encephalopathy management through L-ornithin-L-aspartate administration in dogs
Jin-Ok Ahn,Qiang Li,Young-Heun Lee,Sei-Myoung Han,Cheol-Yong Hwang,Hwa-Young Youn,Jin-Young Chung
Journal of Veterinary Science.2016;17(3)431
[DOI]
27Secondary prophylaxis of hepatic encephalopathy in cirrhosis of liver: a double-blind randomized controlled trial of l-ornithine l-aspartate versus placebo
Shivakumar Varakanahalli,Barjesh C. Sharma,Siddharth Srivastava,Sanjeev Sachdeva,Amol S. Dahale
European Journal of Gastroenterology & Hepatology.2018;30(8)951
[DOI]
28L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis
Ee Teng Goh,Caroline S Stokes,Sandeep S Sidhu,Hendrik Vilstrup,Lise Lotte Gluud,Marsha Y Morgan
Cochrane Database of Systematic Reviews.2018;2019(6)951
[DOI]
29Consenso mexicano sobre probióticos en gastroenterología
M.A. Valdovinos,E. Montijo,A.T. Abreu,S. Heller,A. González-Garay,D. Bacarreza,M. Bielsa-Fernández,M.C. Bojórquez-Ramos,F. Bosques-Padilla,A.I. Burguete-García,R. Carmona-Sánchez,A. Consuelo-Sánchez,E. Coss-Adame,J.A. Chávez-Barrera,M. de Ariño,J. Flores-Calderón,O. Gómez-Escudero,M.S. González-Huezo,M.E. Icaza-Chávez,A. Larrosa-Haro,M. Morales-Arámbula,C. Murata,J.A. Ramírez-Mayans,J.M. Remes-Troche,T. Rizo-Robles,M. Peláez-Luna,E.M. Toro-Monjaraz,A. Torre,M.E. Urquidi-Rivera,R. Vázquez,J.K. Yamamoto-Furusho,F. Guarner
Revista de Gastroenterología de México.2017;82(2)156
[DOI]
30Role of rifaximin in the treatment of hepatic encephalopathy
Jordi Sanchez-Delgado,Mireia Miquel
Gastroenterología y Hepatología (English Edition).2016;39(4)282
[DOI]
31Kinetic mutations in argininosuccinate synthetase deficiency: characterisation and in vitro correction by substrate supplementation
Carmen Diez-Fernandez,Olivia Wellauer,Corinne Gemperle,Véronique Rüfenacht,Ralph Fingerhut,Johannes Häberle
Journal of Medical Genetics.2016;53(10)710
[DOI]
32Screening for minimal hepatic encephalopathy among asymptomatic drivers with chronic liver disease
Mohammad Eltaher Abdelrahman,Saad Zaky Mahmoud,Anwar M. Ali,Haitham Ahmed Abdalla T. El-Khateeb,Ghada A. Mohamed
The Egyptian Journal of Internal Medicine.2018;30(4)217
[DOI]
33L-Ornithine L-Aspartate is Effective and Safe for the Treatment of Hepatic Encephalopathy in Cirrhosis
Sandeep S. Sidhu
Journal of Clinical and Experimental Hepatology.2018;8(3)219
[DOI]
34Probiotics are helpful in hepatic encephalopathy: a meta-analysis of randomized trials
Sammy Saab,Duminda Suraweera,Jennifer Au,Elena G. Saab,Tori S. Alper,Myron J. Tong
Liver International.2016;36(7)986
[DOI]
35Recent advances in hepatic encephalopathy
Victoria Liere,Gurkarminder Sandhu,Sharon DeMorrow
F1000Research.2017;6(7)1637
[DOI]
36The Effects of Probiotics and Symbiotics on Risk Factors for Hepatic Encephalopathy
Daniela Viramontes Hörner,Amanda Avery,Ruth Stow
Journal of Clinical Gastroenterology.2017;51(4)312
[DOI]
37Endogenous Metabolic Modulators: Emerging Therapeutic Potential of Amino Acids
Michael J. Hamill,Raffi Afeyan,Manu V. Chakravarthy,Tony Tramontin
iScience.2020;23(10)101628
[DOI]
38Endogenous Metabolic Modulators: Emerging Therapeutic Potential of Amino Acids
Sahaj Rathi,Radha K. Dhiman
iScience.2018;23(10)65
[DOI]
39Microbiome therapeutics for hepatic encephalopathy
Patricia P. Bloom,Elliot B. Tapper,Vincent B. Young,Anna S. Lok
Journal of Hepatology.2021;23(10)65
[DOI]
40Probiotics can improve the clinical outcomes of hepatic encephalopathy: An update meta-analysis
Li-Na Zhao,Tao Yu,Shao-Yang Lan,Jiang-Tao Hou,Zheng-Zheng Zhang,Shuang-Shuang Wang,Feng-Bin Liu
Clinics and Research in Hepatology and Gastroenterology.2015;39(6)674
[DOI]
41Comparative Efficacy of Treatment Options for Minimal Hepatic Encephalopathy: A Systematic Review and Network Meta-Analysis
Radha K. Dhiman,Kiran K. Thumburu,Nipun Verma,Madhu Chopra,Sahaj Rathi,Usha Dutta,Ashwani K. Singal,Sunil Taneja,Ajay Duseja,Meenu Singh
Clinical Gastroenterology and Hepatology.2020;18(4)800
[DOI]
42L-ornithine L-aspartate for people with cirrhosis and hepatic encephalopathy
Caroline S Stokes,Ee Teng Goh,Hendrik Vilstrup,Marsha Y Morgan,Lise Lotte Gluud
Cochrane Database of Systematic Reviews.2016;18(4)800
[DOI]
43Current Management of Hepatic Encephalopathy
Chathur Acharya,Jasmohan S. Bajaj
American Journal of Gastroenterology.2018;113(11)1600
[DOI]
  Search 
  The Journal 
  Site Statistics 
  Addresses 
  My Preferences 
  Online Submission 

Submit Articles

Alerts

Join us